Louisiana’s governor has allowed a bill to create a psychedelic-assisted therapy pilot program to take effect without his signature. The new effort will use opioid settlement dollars to fund clinical trials aimed at developing alternative treatments such as psilocybin, ibogaine and MDMA.
The Senate and House of Representatives both gave final approval to the proposal from Sen. Patrick McMath (R) in unanimous votes last month. Gov. Jeff Landry (R) chose not to sign or veto it, instead letting it go into effect without his explicit approval.
The House had added MDMA to the scope of the original Senate legislation, and also made technical changes to the text. The Senate objected, however, to what supporters said was an error in the revised version, and members requested that the measure be sent to a bicameral conference committee, where that was resolved before the corrected bill came back to the floor of both chambers for final votes.
Rep. Neil Riser (R), who presented the legislation to the House, said previously that the amendment adding MDMA “put us in positive correlation” with a psychedelics executive order recently signed by President Donald Trump “so that we can look at all different alternatives, including those that are
Read full article on Marijuana Moment
